ABVC BioPharma Inc./$ABVC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Ticker
$ABVC
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
18
Website
ABVC Metrics
BasicAdvanced
$39M
-
-$0.22
0.19
-
Price and volume
Market cap
$39M
Beta
0.19
52-week high
$5.48
52-week low
$0.61
Average daily volume
563K
Financial strength
Current ratio
0.218
Quick ratio
0.032
Long term debt to equity
2.099
Total debt to equity
36.216
Interest coverage (TTM)
-2.95%
Profitability
EBITDA (TTM)
-2.522
Gross margin (TTM)
99.90%
Net profit margin (TTM)
-572.55%
Operating margin (TTM)
-503.54%
Effective tax rate (TTM)
3.26%
Revenue per employee (TTM)
$30,000
Management effectiveness
Return on assets (TTM)
-10.91%
Return on equity (TTM)
-42.42%
Valuation
Price to revenue (TTM)
61.287
Price to book
6.5
Price to tangible book (TTM)
6.5
Price to free cash flow (TTM)
-22.364
Free cash flow yield (TTM)
-4.47%
Free cash flow per share (TTM)
-0.107
Growth
Revenue change (TTM)
1,904.43%
Earnings per share change (TTM)
-84.86%
3-year revenue growth (CAGR)
62.58%
3-year earnings per share growth (CAGR)
-67.80%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ABVC BioPharma Inc. stock?
ABVC BioPharma Inc. (ABVC) has a market cap of $39M as of August 01, 2025.
What is the P/E ratio for ABVC BioPharma Inc. stock?
The price to earnings (P/E) ratio for ABVC BioPharma Inc. (ABVC) stock is 0 as of August 01, 2025.
Does ABVC BioPharma Inc. stock pay dividends?
No, ABVC BioPharma Inc. (ABVC) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next ABVC BioPharma Inc. dividend payment date?
ABVC BioPharma Inc. (ABVC) stock does not pay dividends to its shareholders.
What is the beta indicator for ABVC BioPharma Inc.?
ABVC BioPharma Inc. (ABVC) has a beta rating of 0.19. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.